VANGUARD GROUP INC 13D and 13G filings for OptimizeRx Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-31 11:03 am Purchase | 2025-09-30 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 1,059,109 5.700% | 137,261 (+14.89%) | Filing |
| 2025-04-30 11:22 am Sale | 2025-03-31 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 921,848 4.980% | -99,154 (-9.71%) | Filing |
| 2024-02-13 5:12 pm Sale | 2023-12-29 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 1,021,002 5.620% | -90,409 (-8.13%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 1,111,411 6.480% | 28,635 (+2.64%) | Filing |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 1,082,776 6.090% | 1,082,776 (New Position) | Filing |